期刊
CELL HOST & MICROBE
卷 18, 期 6, 页码 705-713出版社
CELL PRESS
DOI: 10.1016/j.chom.2015.11.005
关键词
-
资金
- US National Institutes of Health Centers of Excellence for Translational Research (CETR) grant [AI-109740]
- NIH [CA-13202]
- Burroughs Wellcome Fund Diversity in Science Postdoctoral Enrichment
- Harvard Medical School
In the Western hemisphere, at least five mammarenaviruses cause human viral hemorrhagic fevers with high case fatality rates. Junin virus (JUNV) is the only hemorrhagic fever virus for which transfusion of survivor immune plasma that contains neutralizing antibodies (passive immunity'') is an established treatment. Here, we report the structure of the JUNV surface glycoprotein receptor-binding subunit (GP1) bound to a neutralizing monoclonal antibody. The antibody engages the GP1 site that binds transferrin receptor 1 (TfR1)-the host cell surface receptor for all New World hemorrhagic fever mammarenaviruses-and mimics an important receptor contact. We show that survivor immune plasma contains antibodies that bind the same epitope. We propose that viral receptor-binding site accessibility explains the success of passive immunity against JUNV and that this functionally conserved epitope is a potential target for therapeutics and vaccines to limit infection by all New World hemorrhagic fever mammarenaviruses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据